
An appeals panel narrowed telemedicine and pharmacy options by blocking mifepristone mailings and requiring more in-person care, and manufacturers quickly pursued emergency relief. NPR’s broader analysis frames this as one of several legal and policy changes since Dobbs that have produced a fragmented system of access across states and providers.
Click a connection line between nodes to view confidence and evidence.